Bivalirudin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Bivalirudin}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{JH}} | ||
'''''For patient information about | '''''For patient information about Bivalirudin, click [[Bivalirudin (patient information)|here]].''''' | ||
{{SB}} | {{SB}} | ||
| Line 15: | Line 15: | ||
====Label Title==== | ====Label Title==== | ||
''' [[ | ''' [[Bivalirudin indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Bivalirudin dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Bivalirudin dosage forms and strengths|Dosage Forms and Strengths]]''' | ||
'''| [[ | '''| [[Bivalirudin contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Bivalirudin warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Bivalirudin adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Bivalirudin drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[Bivalirudin use in specific populations|Use in Specific Populations]]''' | ||
'''| [[ | '''| [[Bivalirudin overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Bivalirudin description|Description]]''' | ||
'''| [[ | '''| [[Bivalirudin clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Bivalirudin nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[ | '''| [[Bivalirudin clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Bivalirudin how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[ | '''| [[Bivalirudin patient counseling information|Patient Counseling Information]]''' | ||
'''| [[ | '''| [[Bivalirudin labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 10:12, 10 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]
For patient information about Bivalirudin, click here.
Synonyms / Brand Names:
Overview
Category
FDA Package Insert
Label Title
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages